The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The role of cetuximab in induction chemotherapy: Comparison of APF-C (nab-paclitaxel, cisplatin, 5-FU + cetuximab) with APF, both followed by chemoradiation therapy (CRT), in patients with locally advanced head and neck squamous cell carcinoma (HNSCC).
 
Douglas Adkins
Research Funding - AstraZeneca (Inst); Celgene (Inst); Galera Therapeutics (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Soligenix (Inst); VentiRx (Inst)
 
Jessica C. Ley
Travel, Accommodations, Expenses - VentiRx
 
Tanya Marya Wildes
No Relationships to Disclose
 
Loren S. Michel
Research Funding - Celgene (Inst)
Travel, Accommodations, Expenses - VentiRx
 
Jason Rich
No Relationships to Disclose
 
Randal Paniello
No Relationships to Disclose
 
Ravi Uppaluri
Consulting or Advisory Role - Merck
Patents, Royalties, Other Intellectual Property - Biolegend; Ebioscience (Inst)
Travel, Accommodations, Expenses - Merck
 
Wade L. Thorstad
No Relationships to Disclose
 
Hiram Alberto Gay
No Relationships to Disclose
 
Kathryn Trinkaus
No Relationships to Disclose
 
Toni Rachocki
No Relationships to Disclose
 
Brian Nussenbaum
No Relationships to Disclose